Skip to content
MarketScale
‹ Back to IndustriesHealthcare

5 A.I. Startups To Watch in 2018

2017 was a year of benchmarks for artificial intelligence (AI) technologies. AI poker-players demolished their human competition.[1] Dermatologists were sidelined as a computer diagnosed potentially cancerous moles with record 90% accuracy.[2] 2018 is amping up to be just as exciting a year as 2017, with numerous startups looking to innovate and disrupt industries of all…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

2017 was a year of benchmarks for artificial intelligence (AI) technologies. AI poker-players demolished their human competition.[1] Dermatologists were sidelined as a computer diagnosed potentially cancerous moles with record 90% accuracy.[2] 2018 is amping up to be just as exciting a year as 2017, with numerous startups looking to innovate and disrupt industries of all kinds. Here are 5 AI tech companies to keep an eye on in the coming year.

  1. Arterys

This startup is looking to change MRI scans for good. Their deep learning software stores a bank of MRI scans in the cloud to compare with new patient scans, allowing for a diagnosis in 15 seconds that would take a human 45 minutes. Last year, Arterys became the first FDA-approved AI platform for their cardiac MRI tech.

  1. Spoke

Spoke’s central AI learns about your company, offering a chatbot for employees to direct frequently asked questions at. Spoke can alert the right person if a light gets left on or the A/C left too high, all while saving your company time.

  1. Freenome

This machine learning software studies blood to determine where bad tissues are in the body, and even whether it’s malignant or not. The more their software screens, the better the results. Freenome is still working toward clinical approval.

  1. SoundHound

This veteran startup is creating a powerful voice assistant that can handle complex questions. By not converting text to speech and instead comprehending a question all in one step, the AI saves time and reduces errors. SoundHound is in a competitive market, but has an edge.

  1. Bowery Farming

By combining vertical farming with AI learning, this startup is creating indoor farms that are 100 times more efficient than traditional farming setups. Its pesticide-free products are already on shelves nation-wide.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Associate-led dental practice successions can take 3–5+ years. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512